Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transplant Proc ; 50(7): 2009-2013, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30177099

RESUMEN

INTRODUCTION: Arterial stiffness and central arterial pressure are important factors in the diagnosis of cardiovascular diseases. The tendency of patients after liver transplantation to reach above-normal BMI values promotes the development of arterial stiffness and lipid disorders. METHODS: The study was conducted on a group of 42 patients after liver transplantation at the Nephrology and Transplantology Outpatient Clinic, Medical University of Warsaw, the Infant Jesus Teaching Hospital, Warsaw 0.5-17 years after surgery. The body composition test was carried out with the Tanita Mc780 device, and the central pressure and pulse wave velocity (PWV) with the Schiller BR-102 PLUS PWA device, using the oscillometric method on the brachial artery. Medical documentation was analyzed and the laboratory parameters values routinely determined during follow-up visits were assessed. RESULTS: There was a statistically significant correlation between central diastolic pressure and BMI (r = 0.46, P < .05), and a lack of correlation between patients' age and PWV value (r = 0.06, P < .05), which indicated the age of patients in this study was not associated the stiffness of their arteries. PWV level in patients after liver transplantation whose BMI value is within the normal range was 7.62 m/s, while overweight and obese patients had PVW values of 8.58 m/s (P < .05). CONCLUSIONS: In conclusion, our data indicate that 1. the level of central arterial pressure increases with the development of stiffness in the arteries; 2. patients after liver transplantation tend to grow in terms of body weight and body fat content over time after surgery; and 3. the level of bilirubin in the blood is significantly increased among patients with fat content above the upper limit of the normal range.


Asunto(s)
Composición Corporal/fisiología , Enfermedades Cardiovasculares/etiología , Trasplante de Hígado/efectos adversos , Complicaciones Posoperatorias/etiología , Rigidez Vascular/fisiología , Tejido Adiposo , Adulto , Bilirrubina/sangre , Determinación de la Presión Sanguínea , Índice de Masa Corporal , Peso Corporal , Arteria Braquial/fisiopatología , Enfermedades Cardiovasculares/sangre , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oscilometría , Complicaciones Posoperatorias/sangre , Periodo Posoperatorio , Análisis de la Onda del Pulso
2.
Transplant Proc ; 50(7): 2085-2089, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30177114

RESUMEN

INTRODUCTION: Arterial stiffness depends on both genetic and environmental factors. The aim of this study was to assess arterial stiffness in patients after heart transplant. METHODS: The study was conducted between May and June 2017. Fifty patients from the Transplantology Clinic of the Institute of Cardiology in Anin, Warsaw, Poland, were enrolled in the study. Pulse wave velocity (PWV), central systolic blood pressure (CSBP), and central diastolic blood pressure (CDBP) were measured and patients' medical records were also analyzed. RESULTS: In the study, 50 patients aged 57.9 years on average were evaluated, of whom 88% were male patients, with average PWV of 8.94 m/s and an average time after transplant of 9.7 years. The study has shown that age (R = 0.77), total cholesterol concentration (R = 0.22, P = .017) and creatinine concentration (R = 0.34; P = .15) show positive correlation with PWV. CONCLUSIONS: Our data indicates that age has significant impact on arterial stiffness and the type of immunosuppressive drugs and transplant rejection episodes do not impact an increase in arterial stiffness.


Asunto(s)
Trasplante de Corazón/efectos adversos , Huésped Inmunocomprometido , Rigidez Vascular , Factores de Edad , Anciano , Estudios de Casos y Controles , Femenino , Rechazo de Injerto/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Polonia , Análisis de la Onda del Pulso , Rigidez Vascular/inmunología
3.
Transplant Proc ; 50(6): 1733-1737, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30056891

RESUMEN

INTRODUCTION: End-stage renal disease (ESRD) has a significant impact on a patient's quality of life (QoL). The optimal treatment for ESRD is kidney transplantation (KTx), which aims to extend and improve QoL. The aim of the study was to assess a QoL in KTx recipients. METHODS: Our study included 118 post-KTx patients. The research tool employed for assessment was a questionnaire consisting of standardized instruments: the 36-item Short Form (SF-36); the Kidney Disease Quality of Life (KDQOL) instrument; and the Depression, Anxiety, and Stress (DASS) scale. In addition, patients were provided with information on their own weight and height, followed by calculation of body mass index. RESULTS: Correlation analysis showed a statistically significant influence of age on general health (R = 0.191, P = .039), physical functioning (R = -0.295, P = .001), and general physical health (R = -0.275, P = .003) assessment. The mean severity of depression, anxiety, and stress among subjects changed over time since KTx. For the post-KTx periods studied (ie, <1 year, 1-10 years, and >10 years), the following changes were observed: for depression, 14.0 vs 11.2 vs 13.1, respectively; for anxiety, 15.6 vs 9.8 vs 14.0, respectively; and for stress, 22.0 vs 13.5 vs 16.8, respectively. CONCLUSION: In this study we found that: 1. QoL in patients after KTx showed a good level for everyday life functioning, and 2. general health assessment, physical functioning, pain, sleep quality, occupational status, vitality, social activity, staff support, and quality of care were major factors associated with QoL after KTx.


Asunto(s)
Fallo Renal Crónico/psicología , Trasplante de Riñón/psicología , Complicaciones Posoperatorias/psicología , Calidad de Vida , Adulto , Anciano , Ansiedad/etiología , Depresión/etiología , Femenino , Humanos , Fallo Renal Crónico/cirugía , Masculino , Persona de Mediana Edad , Estrés Psicológico/etiología , Encuestas y Cuestionarios
4.
Transplant Proc ; 50(6): 1824-1828, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30056908

RESUMEN

INTRODUCTION: Laboratory tests and anthropometric assessments are essential in determining the risk for cardiovascular disease in patients after kidney transplantation (KTx). Patients with hypertension and elevated pulse wave velocity (PWV) are at a higher risk of cardiovascular mortality. The purpose of this study was to determine the role of blood pressure, arterial stiffness, and selected laboratory and anthropometric parameters in estimating the risk of cardiovascular disease in KTx patients. METHODS: A total of 17 KTx patients of the Clinical Department of Gastroenterological Surgery and Transplantation at Central Clinical Hospital of Ministry of the Interior and Administration (MSWiA Hospital) in Warsaw, Poland, were enrolled in this study between 3 to 7 days after undergoing kidney transplantation. Medical records of these patients were reviewed for the selected laboratory parameters. The patients' blood pressure and PWV values were monitored for 24 hours and their body mass index (BMI) values were calculated (BMI ≥ 25.0 is considered overweight). RESULTS: Hemoglobin concentration showed a negative correlation with PWV (r = -0.6), whereas red blood cell distribution width (RDW) showed a positive correlation with the PWV value (r = 0.29). There was a significant correlation (r = 0.21) between overweight measured via BMI and the PWV values. For results of kidney function blood tests, the estimated glomerular filtration rate (GFR) and creatinine levels showed no significant correlation with 24-hour PWV values (GFR r = -0.03; creatinine r = 0.03). CONCLUSIONS: The following were shown to be important indices of cardiovascular risk in the evaluated population of KTx patients: age, BMI, blood pressure, PWV, hemoglobin levels, red blood cells, and RDW%.


Asunto(s)
Enfermedades Cardiovasculares/etiología , Trasplante de Riñón/efectos adversos , Rigidez Vascular , Adulto , Índice de Masa Corporal , Enfermedades Cardiovasculares/epidemiología , Sistema Cardiovascular/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sobrepeso/complicaciones , Polonia , Periodo Posoperatorio , Análisis de la Onda del Pulso , Rigidez Vascular/fisiología
5.
Transplant Proc ; 50(6): 1829-1833, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30056909

RESUMEN

INTRODUCTION: Diseases of the cardiovascular system are the most common cause of death in patients after kidney transplantation (KTx). Pulse wave velocity (PWV) measurement is a simple, noninvasive, and increasingly popular method to assess arterial stiffness, and thus to assess cardiovascular risk. The aim of the study was to compare arterial stiffness and body composition in patients after KTx in the early and late postoperative periods. METHODS: This research was carried out from January to November 2017 at two locations: (1) Department and Clinic of General and Transplant Surgery and (2) Nephrology and Transplantology Clinic Medical University of Warsaw, the Infant Jesus Teaching Hospital, Warsaw, Poland. The study group consisted of 30 patients in the early postoperative period (2-7 postoperative days) and 151 patients in the late period (6 months to 27 years) after KTx. A single blood pressure measurement, PWV, was performed using a Schiller BR-102 plus PWV. Body composition analysis was performed using a Tanita MC-780 device. RESULTS: The average PWV for patients in the early period after KTx was 8.02 ± 2.21 m/s and in the late period 8.09 ± 1.68 m/s. Positive correlations were found between adipose tissue in the abdominal cavity (R = 0.444, P = .033) and PWV value. There was no correlation between the values of PWV and time after transplantation (R = 0.034, P = .777). Upon analyzing patients after transplantation and taking into account the type of dialysis therapy, lower systolic blood pressure (142 ± 21 mm Hg vs 156 ± 24 mm Hg) and diastolic blood pressure (84 ± 13 mm Hg vs 98 ± 11 mm Hg) values were observed in patients treated with hemodialysis compared with those treated with peritoneal dialysis. CONCLUSION: Using PWV measurement, we found that arterial stiffness levels were similar for early and late periods after transplantation.


Asunto(s)
Composición Corporal , Enfermedades Cardiovasculares/etiología , Trasplante de Riñón/efectos adversos , Rigidez Vascular , Adulto , Anciano , Enfermedades Cardiovasculares/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Polonia , Análisis de la Onda del Pulso , Rigidez Vascular/fisiología
6.
Transplant Proc ; 48(5): 1494-7, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27496434

RESUMEN

BACKGROUND: Monitoring of the function of the implanted kidney in renal transplant recipients (RTRs) is one of the superior elements of adequate therapeutic actions. The aim of this study was to assess the conventional and unconventional factors affecting the estimated glomerular filtration rate (eGFR) with the Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Cockcroft-Gault (C-G) formulas among the RTRs. METHODS: The study included 144 RTRs (mean age 52 years). Clinical and laboratory data were analyzed; eGFR was calculated with MDRD, CKD-EPI, and C-G formulas. We compared the results with MDRD as a reference calculating the percentage of reclassifications of chronic kidney disease (CKD) stages. Nutritional status was assessed with a body composition analyzer, Tanita BC 418. RESULTS: Multivariable linear regression analysis with MDRD and CKD-EPI formula as a dependent variable retained the following independent predictors: hemoglobin (Hb) (B = .365; P = .000), and red blood cell distribution width (RDW) (B = -.191; P = .024). Analysis of variance showed the existence of statistically significant differences (all P for trend <.05) between the CKD-EPI, MDRD, and C-G equations within the total scope of eGFR results (51.2 ± 21.2 vs 47.5 ± 18.7 vs 55.6 ± 20.6, respectively) as well as in quartiles of eGFR. CONCLUSIONS: Our data indicate that (1) with a value of eGFR >60 mL/min/1.73 m(2), the MDRD formula shows values that are on average 11% lower than in the CKD-EPI and C-G formulas; (2) with a value of eGFR <60 mL/min/1.73 m(2), the MDRD and CKD-EPI formulas do not show statistically significant differences.


Asunto(s)
Tasa de Filtración Glomerular , Trasplante de Riñón , Estado Nutricional , Adulto , Anciano , Femenino , Humanos , Riñón/fisiopatología , Modelos Lineales , Masculino , Persona de Mediana Edad , Análisis de Regresión , Receptores de Trasplantes
7.
Agents Actions ; 11(4): 339-44, 1981 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7025596

RESUMEN

Ro 21-7634 was examined for oral antiallergic activity in two in vivo models commonly used to evaluate antiallergics. In the rat PCA test, this drug had an oral ID50 of 1.14 mg/kg and was found to be more potent than several other antiallergics including Disodium Cromoglycate (cromoglycate), Oxatomide, Doxanthrazole, Xanoxate, 2,6-bis (ethyoxyoxalylamino) pyridine, PRD-92-EA and M + B 22,948. In contrast to cromoglycate, Ro 21-7634 was found to be an orally active inhibitor of antigen-induced broncho-constriction in passively sensitized rats (ID50 = 0.2 mg/kg). In addition, Ro 21-7634 inhibited antigen-induced histamine release in an in vivo passive peritoneal anaphylaxis test system, following intraperitoneal administration. Ro 21-7634 demonstrated no end organ antagonism toward histamine, metacholine or serotonin in the guinea pig.


Asunto(s)
Hipersensibilidad/tratamiento farmacológico , Piridinas/uso terapéutico , Quinazolinas/uso terapéutico , Administración Oral , Animales , Cobayas , Antagonistas de los Receptores Histamínicos , Inmunidad Materno-Adquirida/efectos de los fármacos , Masculino , Cloruro de Metacolina , Compuestos de Metacolina/antagonistas & inhibidores , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Ratas , Ratas Endogámicas , Antagonistas de la Serotonina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA